Martin Edwards, Director at Verona Pharma plc (VRNA), sold 12,024 shares at $0.84 ($10K) on 2021-05-04, disclosed to the SEC on 2021-05-05.
Scheduled sale ($10k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MORF | BUY | 2023-11-15 | $49K | — | Filing → |
| VRNA | SELL | 2021-02-03 | $14K | — | Filing → |